ACTIVE

ESCAPHARM

Financial year 2025 · Closed on 31/12/2025

Net result119,4 k €+13,6 %over 1 year
Gross margin233,5 k €+19,4 %over 1 year
Equity821,2 k €+14,8 %over 1 year
Workforce0,0 ETP

Identity

Source · BCE/KBO

ESCAPHARM is a Private company with limited liability incorporated in 2008. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Kluisbergen.

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0897.206.151
Incorporation
08/04/2008
Legal form
Private company with limited liability
Registered office
Dalstraat 1
9690 Kluisbergen · FlandreSee on map
Contributed capital
20 000,00 €
Latest accounts
31/12/2025
Average workforce
0,0 ETP
Signals
ProfitableSolid equityLow riskPositive cashflowPositive EBITDA

Financials

Source · NBB, 17 filings

Trend over 17 financial years

20252024202320222021
Income statement
Gross margin233,5 k €195,6 k €199,2 k €165,3 k €182,1 k €
EBITDA225,6 k €195,2 k €198,6 k €164,7 k €181,5 k €
Operating result207,7 k €184,4 k €188,6 k €154,7 k €170,7 k €
Net result119,4 k €105,1 k €106,4 k €81,3 k €89,1 k €
Balance sheet
Equity821,2 k €715,4 k €610,3 k €536,8 k €457,1 k €
Total assets1,5 M €1,3 M €1,1 M €1,1 M €1,2 M €
Cash32,8 k €32,8 k €36,3 k €63,2 k €67,6 k €
Debts634,5 k €563,8 k €492,6 k €574,7 k €666,9 k €
Other
Workforce0,0 ETP0,0 ETP0,0 ETP0,0 ETP–

Valuation

Indicative valuation

As an indication, this company is worth

between 1 M€ and 2,5 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 4 ended

Active mandates

Renaud Mertens

Manager

Active
SOPHIE GLORIEUX

Manager

Active

Ended mandates

Renaud Mertens

Director · since 08 avril 2008

Ended
Sophie Glorieux

Director · since 08 avril 2008

Ended
Sophie Glorieux

Manager · since 08 avril 2008

Ended
SOPHIE GLORIEUX

Manager · until 30 septembre 2014

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date13/08/202622/08/202522/08/202424/08/202325/08/202228/06/2021
General meeting03/08/202620/06/202520/06/202420/06/202320/06/202221/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 17 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202503/08/202613/08/2026DutchPDF
Abridged model31/12/202420/06/202522/08/2025DutchPDF
Abridged model31/12/202320/06/202422/08/2024DutchPDF
Abridged model31/12/202220/06/202324/08/2023DutchPDF
Abridged model31/12/202120/06/202225/08/2022DutchPDF
Abridged model31/12/202021/06/202128/06/2021DutchPDF
Abridged model31/12/201920/06/202024/08/2020DutchPDF
Abridged model31/12/201820/06/201927/06/2019DutchPDF
Abridged model31/12/201720/06/201802/07/2018DutchPDF
Abridged model31/12/201620/06/201716/08/2017DutchPDF
Abridged model31/12/201520/06/201628/06/2016DutchPDF
Abridged model31/12/201420/06/201522/06/2015DutchPDF
Abridged model31/12/201320/06/201403/07/2014DutchPDF
Abridged model31/12/201220/06/201327/06/2013DutchPDF
Abridged model31/12/201120/06/201225/07/2012DutchPDF
Abridged model31/12/201020/06/201129/06/2011DutchPDF
Abridged model31/12/200921/06/201027/07/2010DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 1 M€ and 2,5 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 4 ended

Active mandates

Renaud Mertens

Manager

Active
SOPHIE GLORIEUX

Manager

Active

Ended mandates

Renaud Mertens

Director · since 08 avril 2008

Ended
Sophie Glorieux

Director · since 08 avril 2008

Ended
Sophie Glorieux

Manager · since 08 avril 2008

Ended
SOPHIE GLORIEUX

Manager · until 30 septembre 2014

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Registered office05/04/2019
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Other19/02/2015
    DIVERSEN
    PDF
  • Registered office14/12/2009
    MAATSCHAPPELIJKE ZETEL
    PDF
  • Other23/04/2008
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025119,4 k €↑
  2. 2024
    Annual accounts 2024105,1 k €↓
  3. 2023
    Annual accounts 2023106,4 k €↑
  4. 2022
    Annual accounts 202281,3 k €↓
  5. 2021
    Annual accounts 202189,1 k €↑
  6. 2020
    Annual accounts 202074,4 k €↑
  7. 2019
    Annual accounts 201915,2 k €↑
  8. 2018
    Annual accounts 201812,2 k €↓
  9. 2017
    Annual accounts 201719,1 k €↓
  10. 2016
    Annual accounts 201629,7 k €↓
  11. 2015
    Annual accounts 201536,5 k €↑
  12. 2014
    Annual accounts 201435,5 k €↑
  13. 2013
    Annual accounts 201334,1 k €↑
  14. 2012
    Annual accounts 201229,5 k €↑
  15. 2011
    Annual accounts 201125,8 k €↑
  16. 2010
    Annual accounts 201021,7 k €↑
  17. 2009
    Annual accounts 200919,1 k €
  18. 08/04/2008
    IncorporationPrivate company with limited liability